Article Details
Retrieved on: 2018-04-20 18:52:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div><b>Two Sigma Investments</b> LP acquired a new position in shares of Cascadian Therapeutics Inc (NASDAQ:CASC) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 48,835 shares of the ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here